“At this stage in India, when ‘R0’ has come down to below one in all states then the epidemic in India is self-limiting in that sense…so, if it is self-limiting, then should we be financing it (Covid-19 vaccine)?” Indu Bhushan, CEO of Ayushman Bharat scheme, said at a webinar on Tuesday.“At this stage in India, when ‘R0’ has come down to below one in all states then the epidemic in India is self-limiting in that sense…so, if it is self-limiting, then should we be financing it (Covid-19 vaccine)?” Indu Bhushan, CEO of Ayushman Bharat scheme, said at a webinar on Tuesday.Read More
